journal article·2019-12-04Open access

Propofol inhibits proliferation and metastasis by up-regulation of miR-495 in JEG-3 choriocarcinoma cells

Hai Sun, Yingjian Wang, Wenyu Zhang

Abstract

Choriocarcinoma is a rare gestational trophoblastic tumour. Propofol is one of the commonly used intravenous anaesthetic agents and exerts an anti-tumour role in multiple cancers. However, the effect of propofol on choriocarcinoma has not been well explored. We investigated the effect of propofol on JEG-3 cells. The effects of propofol on cell proliferation and metastasis were determined. The expression of miR-495 was suppressed while Twist1 overexpressed. Cell viability, migration and invasion were respectively measured using CCK-8 assay and transwell migration/invasion assay. The expression of miR-495, AKT1 and Twist1 was detected using qRT-PCR. Western blot analysis was performed to assess the expression levels of EMT- and proliferation-related factors, and TGF-β pathway proteins. Propofol treatment significantly inhibited cell proliferation, migration and invasion, and reduced the releasing of EMT. miR-495 was up-regulated by profocol, and miR-495 inhibition reversed the effect of propofol on cell proliferation and metastasis in JEG-3 cells. Furthermore, propofol decreased the expression of AKT1 and Twist1 through up-regulating miR-495, and Twist1 participated in the regulation of propofol on TGF-β signalling inactivation in JEG-3 cells. This study demonstrates that propofol suppresses cell proliferation and metastasis through up-regulation of miR-495 and down-regulation of Twist1 in JEG3 cells. Highlights Propofol inhibits proliferation and metastasis in JEG-3 cells; miR-495 is up-regulated by propofol in JEG-3 cells; miR-495 suppression blocks the effect of propofol in JEG-3 cells; Propofol decreases Twist1 expression through up-regulating miR-495; Propofol inhibits TGF-β signalling via regulation of Twist1.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer, Stress, Anesthesia, and Immune Response · Neonatal Respiratory Health Research · Congenital Diaphragmatic Hernia Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Anesthesiology, China-Japan Union Hospital of Jilin University

Department of Gynecology and Obstetrics, China-Japan Union Hospital of Jilin University

References (41)

Show source-provided references
1. Kurman RJ, Carcangiu ML, Herrington CS. WHO classification of tumours of female reproductive organs. Lyon: International Agency for Research on Cancer (IARC); 2014.
2. 10.3181/00379727-93-2275710.3181/00379727-93-22757 ↗
3. 10.1016/j.ajog.2010.06.07310.1016/j.ajog.2010.06.073 ↗
4. 10.1016/j.canlet.2009.10.00510.1016/j.canlet.2009.10.005 ↗
5. 10.1016/S1470-2045(07)70204-810.1016/S1470-2045(07)70204-8 ↗
6. 10.1016/S0092-8674(04)00045-510.1016/S0092-8674(04)00045-5 ↗
7. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 2005;302:1–12.
8. 10.18632/oncotarget.998110.18632/oncotarget.9981 ↗
9. 10.18632/oncotarget.503710.18632/oncotarget.5037 ↗
10. 10.1038/onc.2010.61810.1038/onc.2010.618 ↗
11. 10.1007/s13238-014-0088-210.1007/s13238-014-0088-2 ↗
12. 10.1007/s13277-015-3686-610.1007/s13277-015-3686-6 ↗
13. 10.1016/j.canlet.2012.03.02910.1016/j.canlet.2012.03.029 ↗
14. 10.1292/jvms.12-043610.1292/jvms.12-0436 ↗
15. 10.1016/j.bbrc.2011.06.17210.1016/j.bbrc.2011.06.172 ↗
16. 10.1016/S0304-3835(02)00210-010.1016/S0304-3835(02)00210-0 ↗
17. 10.3727/096504014X1389037041020310.3727/096504014X13890370410203 ↗
18. 10.1002/cbin.1003410.1002/cbin.10034 ↗
19. 10.1007/s00540-011-1163-y10.1007/s00540-011-1163-y ↗
20. 10.18632/oncotarget.1682610.18632/oncotarget.16826 ↗
21. 10.1016/j.devcel.2008.05.00910.1016/j.devcel.2008.05.009 ↗
22. 10.3109/07357907.2016.115669010.3109/07357907.2016.1156690 ↗
23. 10.1016/j.biopha.2017.11.13810.1016/j.biopha.2017.11.138 ↗
24. 10.1158/0008-5472.CAN-17-300910.1158/0008-5472.CAN-17-3009 ↗
25. 10.1002/cbin.1091610.1002/cbin.10916 ↗
26. 10.1186/s12967-014-0279-x10.1186/s12967-014-0279-x ↗
27. 10.1007/s13277-014-1677-710.1007/s13277-014-1677-7 ↗
28. Z S, XK H, QP W. Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression. Eur J Gynaecol Oncol. 2014;35:688.
29. Wang P, Chen J, Mu LH, et al. Propofol inhibits invasion and enhances paclitaxel- induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug. Eur Rev Med Pharmacol Sci. 2013;17:1722–1729.
30. Xu YB, Du QH, Zhang MY, et al. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci 2013;17:2486.
31. Wu KC, Yang ST, Hsia TC, et al. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res. 2012;32:4833–4842.
32. 10.1016/S1499-3872(13)60048-X10.1016/S1499-3872(13)60048-X ↗
33. 10.4238/2015.July.17.2010.4238/2015.July.17.20 ↗
34. Wei T, Zhu W, Fang S, et al. miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX. Am J Cancer Res. 2017;7:628.
35. 10.1007/s10549-010-0734-110.1007/s10549-010-0734-1 ↗
36. 10.1158/1541-7786.MCR-14-010510.1158/1541-7786.MCR-14-0105 ↗
37. 10.1080/15384101.2015.100604810.1080/15384101.2015.1006048 ↗
38. 10.1158/0008-5472.CAN-10-233010.1158/0008-5472.CAN-10-2330 ↗
39. 10.1073/pnas.132291311110.1073/pnas.1322913111 ↗
40. 10.1101/gad.248963.11410.1101/gad.248963.114 ↗
41. 10.1016/j.ceb.2009.01.02110.1016/j.ceb.2009.01.021 ↗